By Lauren VanDenBoom
Share

December 3, 2019

Of course, we think hc1’s High-Value Care Platform™, which delivers precision testing and prescribing supported by bioinformatics and secured in a HIPAA-compliant AWS infrastructure, is worth watching in 2020. Here are some other health tech innovations and innovators we think you should be keeping an eye on too.

Wearable Medical Devices are being used for more than just counting steps and measuring heart rate. Proteus Digital Health has combined ingestible sensors, a wearable sensor patch, and a mobile app to measure medication treatment effectiveness, patient activity, and rest. Neurotech’s remote, real-time EEG monitoring is being used to detect electrographic seizures and even baseline changes that may not be physically noticeable.

3D bioprinting is allowing companies to create printed parts for medical transplantation and implantation. Cyfuse Biomedical is working on a bioprinter called Regenova that can print biological components, such as digestive and urinary organs cartilage, blood vessels, tubular tissues, and even functional liver. For researchers, pharmaceutical companies and others who want to put a bioprinter in their own lab,  BioBots has created a desktop bioprinter that utilizes specially formatted bio-inks. By putting this technology in more hands, innovation in uses for bioprinting will come even faster.

Blockchain is not just for cryptocurrency anymore. The decentralized data storage model is being used to keep medical data secure and transferrable while also reducing costs. SimplyVital Health is making its open-source Nexus Health platform available to the entire healthcare community to store and retrieve information. The company has also recently partnered with a genomics and precision medicine company to apply blockchain security to protect DNA sequencing data. British company, Medicalchain is helping to maintain the integrity of health records, while also establishing a single point of truth. The company is putting patients’ records in their own hands to allow and revoke access. Colorado startup, BurstIQ is using blockchain to securely manage huge amounts of complete and up-to-date patient health data.

Artificial Intelligence (AI) is also making its way into healthcare by way of intelligent machines for risk analytics, medical imaging, diagnosis, and drug discovery, as well as workflow and patient management. Some of the biggest names in technology are behind AI healthcare innovations, such as Intel, IBM, Microsoft, and Google parent, Alphabet.

Genomics is also changing the way healthcare is delivered by making more personalized medicine possible. Genomic Health is using computational biology and genetic diagnostics to inform breast, prostate, colon, and lung cancer management and treatment decisions. Bluebird Bio is using gene therapy to detect, cure, and treat diseases. They are currently researching treatment for sickle cell disease, B-thalassemia, and multiple myeloma, as well as ways to help a patient’s own immune system destroy cancer cells. hc1 PGx Advisor™ is facilitating prescriber and pharmacist engagement in personalized medicine by combining conventional Medication Therapy Management (MTM), Pharmacogenomics (PGx), and integrated engagement and monitoring workflows specific to the individual patient. The unique approach ensures the right patient gets the right prescription based on their unique genetic traits.

 

References:

  1. Marr, B. (1 Nov 2019). The 9 biggest technology trends that will transform medicine and healthcare in 2020. Forbes. https://www.forbes.com/sites/bernardmarr/2019/11/01/the-9-biggest-technology-trends-that-will-transform-medicine-and-healthcare-in-2020/#221bfcf872cd
  2. Phaneuf, A. (23 July 2019). Here are the top health tech companies and startups developing wearable medical devices. Business Insider. https://www.businessinsider.com/wearable-tech-companies-startups?IR=T
  3. Science Service. (15 Apr 2019). Top 10 companies in medical 3D printing | 3D bioprinting. Dr. Hempel Digital Health Network. https://www.dr-hempel-network.com/digital-health-technolgy/top-10-companies-in-medical-3d-printing/
  4. Daley, S. (1 Oct 2019). 15 examples of how blockchain is reviving healthcare. Builtin. https://builtin.com/blockchain/blockchain-healthcare-applications-companies
  5. Meticulous Research. (19 Sept 2019). Top 10 artificial intelligence companies in healthcare market. Meticulous Blog. https://meticulousblog.org/top-10-companies-in-healthcare-artificial-intelligence-market/
  6. Jacobs, CFA, J. (11 Apr 2019). 4 leading companies in genomics. Global X by Mirae Asset. https://www.globalxetfs.com/4-leading-companies-genomics/
By Lauren VanDenBoom
Share

hc1 and Becker’s Healthcare have partnered to bring together leaders in precision medicine for a free, two-day, special virtual event on November 17-18. The Precision Health Virtual Summit will focus on the changes our care delivery system needs as it transitions from fee-for-service to value-based care reimbursement models. Plus, public health leaders will share how the pandemic, as well as political and civil unrest, are impacting healthcare today for patients, providers, payors, and employers. 

Registration is open now at www.hc1.com/summit

Every patient down to their very own genetic makeup is unique. So why are we still treating everyone the same? The one-size-fits-all, trial-and-error healthcare model results in missed diagnoses, protracted illnesses, and even premature death.This outmoded approach also wastes $765 billion annually.

The answer to the problem – Precision Healthcare. When we start treating patients as individuals we deliver improved care and financial performance together. We’re bringing together leaders in the field of precision health to share how they’re solving precision health without budget-busting investments. 

The event will host some of America’s top thought leaders in Precision Health including:

  • Keynote speaker: Stephen K. Klasko, MD, MBA, President, Thomas Jefferson University, CEO, Jefferson Health
  • Brad Bostic, Founder, Chairman, and CEO at  hc1
  • Shez Partovi, MD, AWS Worldwide Lead: Healthcare, Life Sciences, Genomics, Med Devices
  • Donald Brown, MD, CEO at LifeOmic
  • Atul Butte, MD, PhD, Chief Data Scientist for University of California Health System, Priscilla Chan and Mark Zuckerberg Distinguished Professor of Pediatrics, Bioengineering and Therapeutic Sciences, and Epidemiology and Biostatistics at UCSF
  • Jane Dickerson,  PhD, DABCC, Co-Founder of PLUGS, Director of Chemistry and Reference Lab Services at Seattle Children’s
  • Steven Goldberg, MD, MBA, Quest Diagnostics, VP, Medical Affairs, Population Health and Chief Health Officer
  • Dave Dexter, CEO at Sonora Quest
  • Patrick Holland, Chief Financial Officer and Treasurer at Atrius Health
  • David Carmouche, MD, President at Ochsner Health Network, SVP of Community Care, & Exec. Dir. of Accountable Care Net.
  • Yolangel “Yogi” Hernandez Suarez, MD, Florida International University Associate Dean for Clinical and Community Affairs & Former VP and CMO at Humana for Population Health
  • Gary Stuck, DO, FAAFP, CMO at Advocate
  • Megan Mahoney, MD, Stanford Health Care Chief of Staff & Clinical Professor Medicine in Primary Care & Population Health
  • Latha Palaniappan, MD, MS, Stanford Medical Professor of Medicine in Primary Care & Population Health
  • Mick Raich, CEO at Vachette Path and Stark Auditing
  • Ken Furton, Florida International University Provost, Executive Vice President and Chief Operating Officer
  • Jessica Saba, PharmD, BCGP, Director, Value Based and Population Health Pharmacy at Highmark
  • Laura K. Mark, PharmD, Vice President of Pharmacy at Allegheny Health Network
  • Stu Beatty, PharmD, Director of Strategy and Practice Transformation at Ohio Pharmacy Association, Founder of Strategic Pharmacy Initiatives, Associate Professor of Clinical Pharmacy at The Ohio State University
  • Jim Gartner, EVP of Clinical and Product Strategy at AssureCare
  • David Freeman, GM of Information Ventures at Quest Diagnostics

Summit attendees will learn:

  • How leaders are addressing the top healthcare challenges faced by health systems, hospitals, campus leaders, and employers during this pandemic with precision health
  • The keys to how precision health can improve financial performance by leveraging existing data assets, eliminating waste, and delivering better patient outcomes without hiring an army of analysts or more pricey data scientists
  • How our panel of exceptional health system leaders are balancing volume-based fee-for-service and value-based care models together
  • Why the proliferation and adoption of a new category of Precision Health Insight Networks (PHINs) is needed more than ever and how these networks have played a crucial role in public health during the pandemic
  • What needs to happen next to deliver countless breakthroughs that will forever change the way healthcare is delivered, saving millions of lives and billions of dollars 

Anyone can attend, and the content will be of most interest to:

  • Hospital and health system leaders and payers who wish to reduce waste while saving more lives
  • Employers who want to protect their teams during the COVID-19 pandemic and keep their students on campus healthy
  • Leaders who will determine the future of data-driven care with precision health
  • Healthcare providers who want to deliver better outcomes for their patients
  • Educators who want to shape the curriculum for medical and allied health professions

We certainly hope you’ll join us for this important conversation. Visit www.hc1.com/summit for more information or to register today! 

By Lauren VanDenBoom
Share

August 6, 2019

There’s a new framework for judging the success of healthcare and it’s based on outcomes. This new paradigm of patient-centered care is now the bar that must be met for reimbursement. It requires delivering healthcare that is safe, effective, efficient, patient-centered, timely, and equitable.

To meet all these standards, the use of health informatics has grown increasingly sophisticated. Health informatics is an emerging science that combines healthcare, information technology, and communications to share medical data, facilitate coordination between providers, and encourage patient participation.

The ways in which it has improved patient outcomes in the last 5 years can be observed most readily in the following areas.

(1) Reduced error through shared medical data

The increased collection and automation of electronic health records (EHRs) reduce negative outcomes due to human error. Information gathered by a primary care provider is increasingly deposited into an EHR to keep track of a patient’s medications, allergies, and possible interactions. This information can be accessed to check for potential problems when a new medication is prescribed – especially in an emergency situation, or if the patient is unconscious. 

Well-maintained EHRs ensure patients get the proper medication the first time to prevent allergic reactions. They can be set up to warn a provider before ordering a test a patient has already received or maybe it’s a high-cost to the patient. 

In a paper-based setting, identifying potential safety problems is difficult and time-consuming. This can lead to medical consequences that take years to correct. Conversely, EHRs can expose potential safety problems before they occur, and help providers avoid serious medical errors thus leading to better patient outcomes. 

(2) Increased efficiency through coordination

The last 5 years have seen a great increase in the amount of medical data created, used, edited, and viewed by multiple healthcare entities (such as clinicians, hospitals, insurance companies, and patients). As a result, many hands need to ‘touch’ these records. 

Coordinating all this has been a crucial part of improved patient care, and informatics has greatly improved this. Clinicians who use this technology and incorporate data into their daily workflow see improved provider and patient satisfaction. 

(3) Increased patient involvement, compliance through portals

A patient’s success story often depends to a large degree on their own compliance. With increasing access to portal platforms, many patients are taking a more active role in managing their health – an essential element of patient-centered care. 

Portals also provide patients with a way to educate themselves, keep track of medications, and manage symptoms. They provide a more efficient way to interact with doctors and nurses more easily, and this leads to better outcomes as well. 

Additionally, there is a rising patient demand for access to their own healthcare data. This has led to more personal use of EHRs such as providing a greater role for family and friends and sharing information and resources with others who have the same conditions. For example, the CHESS program, implemented as a result of a study by the Agency of Healthcare Research and Quality (AHRQ), has helped people with chronic illnesses (such as AIDS or cancer) more readily find access to resources, referrals, health services, and care.

Convenience is also a factor for improving patient compliance – and therefore patient outcomes. EHRs have added a great deal of convenience with regards to health care transactions such as e-prescribing (having prescriptions ordered and ready for pick-up before they leave the provider’s office), filing insurance claims from the provider’s office, and even accessing files or prescriptions away from home or while on vacation. 

(4) Improved decision support

Clinicians and healthcare providers make a remarkable number of decisions about healthcare every day. EHRs help them make more efficient, more effective decisions about the care for their patients, leading to improved outcomes. They do this by:

  • Improving aggregation, analysis, and communication of patient information
  • Providing alerts and reminders
  • Offering supporting evidence for diagnostic and therapeutic decisions

Interfacing data from various medical devices through custom applications provides not only valuable data with regards to a patient’s health, but also provides essential clinical decision support to help prevent patient harm.

Next era of health informatics – unlocking the potential of lab data

Front office and the exam room data has been corralled and utilized to help improve patient outcomes through informatics. However, the data is still siloed.

Silos are a fact because most healthcare institutions have their own lab information systems (LIS). None of these data caches talk to each other. You can export reports, but then what do you do with the information? For example, EHRs can provide the test results, but they cannot intuit where wasteful lab testing is happening.

The answer is to transform that lab data into personalized healthcare insights with a solution like hc1 Test Utilization™. This tool takes all lab data and builds a healthcare relationship matrix so clinicians gain clearer insights. 

hc1 Test Utilization integrates everything to create a treasure trove of normalized data by:

  • Removing duplication that comes from variants in naming and coding
  • Standardizing the range differences (for example, normal may be a range of 1 to 5 in one place, and 2 to 4 in another) 
  • Ironing out the clinical variation and getting every physician on the same page

Health informatics provides a number of efficient solutions for improving patient outcomes. However, there’s a rich source data that is underutilized because lab data is siloed. An informatics tool such as Test Utilization provides a way to see test results at a global level. It is the next step in the evolution of health informatics and patient-centered healthcare.

By Lauren VanDenBoom
Share

November 12, 2019

Efforts to implement value-based healthcare (improved outcomes for less cost) are becoming increasingly vital as global, particularly U.S., healthcare spending soars. Global healthcare spending is projected to increase to $10.1 trillion by 2022. Estimates suggest $3 trillion of that money is spent on waste, for which the United States accounts for a third. The United States healthcare spend is the highest, 5 percent more than the next highest-spending country.1,2

 

Value-based healthcare has brought information technology, and particularly data management, into the forefront. Determining value, as well as increasing value, requires significant data analytics to identify, measure, and improve outcomes. For efficient and accurate analysis, data must first be accessible and relational. This means retrieving and aligning data for medical and health care services, supportive services, processes, research, and innovation.1

 

Historically health system data has been anything but accessible. For years data has been collected and defined by siloed entities in non-standardized and legacy IT systems. Health informatics, however, is increasingly connecting systems and allowing real-time analysis of this complex information. Bridges can now be built between the silos and the data stored within can be combined and shared more easily.2

Improved data management resulting from the shift to value-based care is manifesting itself in several important ways. Significant improvements in clinical data exchange are already occurring and are predicted to occur in the next decade.3 These improvements include:

Improved data sharing within and across healthcare networks. More records system vendors are working together and solutions like the hc1 High-Value Care Platform™ are making data more manageable and transferable. The federal government is also calling for healthcare providers and vendors to use systems that facilitate rather than impede the exchange of information.3

Added communications capability and easier interaction for increasingly tech-savvy patients and healthcare providers. Gone are the days when a majority of patients were uncomfortable with technology and providers avoided contact with them outside of office visits. Health system portals are giving patients and providers easy access to records and efficient means of secure communication that save time and improve interactions. This increased communications capability also applies to interaction between healthcare providers, such as between primary care providers (PCPs) and specialists or PCPs and pharmacists.3

Personalized care and precision medicine. Through the use of pharmacogenetic testing, we can learn how our bodies are likely to process and react to prescribed medication. With the results in hand, as well as knowledge of lifestyle, allergies, and current medications, healthcare providers can personalize treatment. Precision medicine, however, requires analysis of these multiple data points. Solutions like hc1 PGx Advisor™ are helping providers efficiently access and analyze this data.

Faster transition from research to practice. Insights gained through research once took years before becoming part of regular medical practice. Providers strapped for time were unable to easily stay current on all of the latest publications and guidelines. With modern data systems, guidelines and recommendations can be loaded into clinical data systems and made available for reference during related patient interactions. Having relevant, real-time clinical information helps guide prescribing, testing and treatment while reducing waste and improving outcomes.3

In 2011, hc1 was born from our founder’s belief that every patient is unique and should be treated that way. Today the hc1 High-Value Care Platform™ eliminates waste and personalizes care for health systems and diagnostic laboratories nationwide by turning previously static lab data into actionable healthcare insights. Using the hc1 platform, health systems can improve clinical outcomes and reduce medical spend. Request a demo to learn more.

References

  1. Leung, T. I., Merode, G.G. (2018 Dec 22). Value-Based Health Care Supported by Data Science. Fundamentals of Clinical Data Science pp 193-212. https://link.springer.com/chapter/10.1007/978-3-319-99713-1_14.
  2. Kimpen, J. (12 Feb 2019). Here’s how to make ‘value-based healthcare’ a reality. World Economic Forum. https://www.weforum.org/agenda/2019/02/here-s-how-to-make-value-based-healthcare-a-reality/
  3. HDM Staff. (27 Sept 2019). How IT will impact healthcare in the next decade. Health Data Management. https://www.healthdatamanagement.com/news/how-it-will-impact-healthcare-in-the-next-decade
By Lauren VanDenBoom
Share

November 27, 2019

According to the World Health Organization, “the safety and availability of specific health services is directly influenced by the availability and functionality of commodities needed to provide those services.”1 Among those key commodities is information technology (IT).

As technology advances, so must a health system’s IT infrastructure to not only take advantage of new capabilities, but to ensure continued stability and security. IT infrastructure improvements can also increase value in patient care, as well as help to attract and retain valuable talent for the healthcare system.

As the end of the calendar year approaches, many organizations are considering ways to use budget remainders before the end of the year or planning budgets for the coming year. IT infrastructure improvement should be part of the wish list.

Some things to consider when evaluating new infrastructure components or determining an area of focus:

Scalability: Will the solution be able to adapt to changing demands?

Data Integration: Can data be combined, analyzed, and transferred as needed?

Security: Will data and critical system performance be protected?

Connectivity: Are providers and patients able to connect to applications and information when and where they need to?

Performance: Can critical tasks be performed in an efficient and consistent manner?

When beginning the planning process it is critical to involve all stakeholders from beginning to end. The people who will build the solution, support the solution, and use the solution should all have an opportunity to share their needs and evaluate options. Also important is to identify internal strengths within your team and supplement with external experts as needed, for example, consultants may be needed for IT security, network design, or data analytics.

hc1 offers a suite of cloud-based, high-value care solutions that enable healthcare organizations to transform business and clinical data into the intelligence necessary to deliver on the promise of personalized care, all while eliminating waste. Visit www.hc1.com to learn more.

References

  1. World Health Organization. (2019). Infrastructure and technologies. 
  2. Luxon L. (2015). Infrastructure – the key to healthcare improvement. Future hospital journal2(1), 4–7. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465866/
By Lauren VanDenBoom
Share

October 6, 2020

During the 2020 American Society of Clinical Pathology (ASCP) Annual Meeting, Quest Diagnostics was announced as a 2020 ASCP Choosing Wisely Champion for Quest®  Lab Stewardship™ powered by hc1®. The recognition honors the significant impact hc1 and Quest are making together using advanced lab analytics for precision health. 

The Choosing Wisely® Champions program, in collaboration with the American Board of Internal Medicine (ABIM) Foundation, recognizes contributions to the Choosing Wisely campaign, serves to inspire others to drive change in healthcare and helps clinicians learn from the outstanding examples of others. 

Choosing Wisely is an initiative of the ABIM that offers guidelines for testing and therapy with a goal of reducing unnecessary laboratory services while maintaining a high standard of quality in patient care. Choosing Wisely recommendations improve patient care and reduce healthcare costs, and the Choosing Wisely Champions encourage their colleagues to use the right test at the right time for the right cost.  

Nearly 70 percent of all medical decisions are based on laboratory results. An estimated 13 billion laboratory tests are performed in the United States each year. Through this objective evidence, doctors and other healthcare professionals daily make informed diagnostic and therapeutic decisions. 

While the more than 3,500 types of laboratory tests available are a rich source of information, as much as 21 percent of all those ordered are unnecessary or unwarranted based on the patient’s symptoms. To provide high-value care, healthcare organizations must identify and manage this waste. 

The modern laboratory test menu is complex, making it unrealistic for healthcare providers to become experts in laboratory medicine. Nearly 15 percent of healthcare providers say they are uncertain about which tests to order. Laboratory leaders have the knowledge to educate healthcare providers, but are themselves strapped for time and resources. They are focused on producing high-quality test results in a timely manner. Healthcare providers and laboratorians rarely meet to discuss how they could work together to improve laboratory usage and patient care. 

Replacing inefficient practices with a cost-effective utilization strategy requires dedication, resources and the right solutions. With a focused, data-driven program in place, health systems can provide high-value care for patients while increasing internal efficiencies and lowering costs.

The savings that can be realized through implementing an effective utilization program can more than make up for the expense of putting the appropriate resources and team in place to do so. Estimates project that healthcare systems could reduce costs of up to $5 billion per year if they were just to eliminate redundant tests. Even more savings, and patient satisfaction, could be realized through increasing use of appropriate tests that diagnose diseases early, when treatment can be more effective. In addition, insurers are also demanding evidence for the efficacy of a therapy or intervention and denying payment if it is not provided. 

To combat waste in lab test ordering, some health systems and hospitals have implemented test utilization programs to identify patterns in lab ordering trends. However, these programs often require time-consuming manual uploads of data or use platforms that cannot pull from disparate enterprise systems or provide real-time test ordering guidance. Quest, with hc1, created Quest Lab Stewardship to overcome these challenges. 

Quest Lab Stewardship powered by hc1 helps healthcare leaders and lab administrators optimize laboratory utilization, reduce clinical variation, and ensure the right patient gets the right test at the right time. This innovative technology employs machine learning to harmonize laboratory testing across a hospital’s laboratory and other IT systems and matches ordering patterns against guidelines, such as those of Choosing Wisely. The user can quickly filter and analyze this data to identify ordering patterns that may adversely impact care or costs.  

“Lab testing is essential to delivering cost-effective healthcare, but hospital test utilization programs often fail to maximize its value,” said Lee H. Hilborne, MD, MPH, DLM (ASCP), Senior Medical Director, Medical Affairs, Quest Diagnostics, and Chair of the American Society for Clinical Pathology’s Effective Test Utilization Subcommittee (Choosing Wisely). “With Quest Lab Stewardship, health systems have an intuitive solution to identify the right test, for the right patient, at the right time – the same goal embodied in the Choosing Wisely Award.” 

Quest and hc1 are currently working to expand Quest Lab Stewardship to include automated management and alerting to ensure COVID-19 patient continuum of care and risk assessment. Recent studies show that health conditions post-COVID-19 infection may require additional, ongoing monitoring and care for patients as they struggle to return to their usual health pre-infection. Laboratory testing is one critical tool for healthcare providers to develop a baseline understanding of their patients’ health and to manage patient care through a diagnosed or suspected COVID-19 case. Armed with key insights from laboratory testing, Quest Lab Stewardship powered by hc1 helps illuminate a care pathway.

Hospital and health system lab administrators interested in learning more about Quest Lab Stewardship powered by hc1 should click here.

By Lauren VanDenBoom
Share

August 31, 2020

With a global pandemic dominating the news cycle and changing our daily lives, it’s easy to forget about the other epidemic that kills Americans daily: opioid overdose. 

August 31 is International Overdose Awareness Day, a global event to raise awareness of overdose and reduce the stigma of drug-related death. Overdose death is preventable and is still occurring in spite of COVID-19. In observance of the day, we want to call attention to the impact opioid misuse has in the United States, as well as resources for learning more. 

In the coming weeks we will reintroduce the topic of opioid misuse in our conversations and in our blog because with attention, understanding, and vigilance, this epidemic too can be overcome. 

  • 128 people die every day from an opioid overdose. Forty-one of those deaths involve a prescription opioid. 
  • During 2018, there were 67,367 overdose deaths in the United States and 46,802 of those overdose deaths involved opioids.
  • Many opioid overdoses also involve other drugs.
  • Anyone who takes prescription opioids can become addicted to them. As many as one in four patients receiving long-term opioid therapy in a primary care setting struggle with opioid addiction.
  • An estimated 10.3 million Americans aged 12 and older misused opioids in 2018, including 9.9 million prescription pain reliever misusers and 808,000 heroin users.
  • More than 191 million opioid prescriptions were dispensed to American patients in 2017.
  • Responsible opioid prescribing practices that include risk assessment, checking the state’s prescription drug monitoring program (PDMP), laboratory testing and patient education can prevent misuse that may lead to addiction and overdose. 
  • Opioid Stewardship Committees can be an effective way to start implementing consistent, responsible prescribing and vigilant monitoring practices in healthcare organizations. 
  • More information about opioid misuse and overdose can be found by visiting:
By Carson Goff
Share

December 3, 2020

On November 13th, 1789, Ben Franklin, wrote a letter to Jean-Baptiste Leroy saying, “Our new Constitution is now established, and has an appearance that promises permanency; but in this world, nothing can be said to be certain, except death and taxes.” Ben Franklin’s words certainly still hold true today. However, in this article, I plan to draw attention to a crisis that requires major action and change to prevent premature death, and, unfortunately, I will also draw the necessary correlation to the almighty dollar and tax revenue.

While preparing to write this article it has been difficult to find words or examples to put the year 2020 into perspective while bringing up yet another heart-wrenching topic. There is no doubt that this year will always be remembered for a time of uncertainty. This moment in our country’s history will leave an indelible mark on all generations, hopefully, many positive changes will take effect but there is no doubt some will have negative memories. Specifically, the pandemic has been devastating on so many levels, and racial injustice (and the following riots) have been tragic. These events have shaken up the United States and have forced individuals to ask themselves very difficult questions about their personal health and safety and the health and safety of their loved ones. What’s worse? We have other life-altering healthcare crises that continue to persist. The opioid crisis was already serious, but it has intensified during the pandemic.

Recently, my colleague, Lauren VenDenBoom, brought it to my attention that Monday, August 31st was International Overdose Awareness day. She wrote a blog post articulating the harsh truth that 128 people die every day from an opioid overdose!! She cited many other staggering and sobering facts here: https://www.hc1.com/blog/lets-not-forget-the-other-epidemic-opioid-overdose/.

My CEO, Brad Bostic, also sent me an article on Sunday evening that argues how the opioid crisis is “a unique product” of US health care. In the article written by Alexis Keenan and Adriana Belmonte of Yahoo Finance, they reported that “U.S. states are claiming that opioid manufacturers, distributors, and others who fueled the country’s decades-long opioid crisis will cost the economy at least $2.15 trillion by the year 2040. Between 2007 and 2019, the states estimated that their systems took a $630 billion hit. Anticipated costs of $1.53 trillion from 2020 to 2040 are estimated to run up the rest of the tab. The figure was reported in a filing made public Monday in the Southern District of New York in the bankruptcy case for OxyContin maker Purdue Pharmaceutical.” You can access the entire article here: https://news.yahoo.com/opioid-crisis-health-care-system-165837992.html

opioid crisis

+ The picture above is of Cataldo Ambulance medics and other first responders reviving a 32-year-old man who was found unresponsive and not breathing after an opioid overdose on a sidewalk in Everett, Massachusetts. (REUTERS/Brian Snyder)

$2.15 trillion dollars is as shocking of a number as I can imagine being linked to the opioid crisis. Do I even have to start contextualizing how big a number that is when it starts with the letter “t”? I have spent my career in some sort of sales capacity which typically requires me to create cost-benefit analysis or return on investment calculations. Those analyses have provided justification for the various organizations I engage that are evaluating an investment in software solutions. It made me think, do we really need to cost-justify lives being lost? I hope not but change is often slow unless we create the necessary urgency to gain attention and priority. Thus, the cost of the loss of lives is unfathomable when you look at it from a tax revenue perspective, but much more importantly, the loss of life means that a mom or dad, son or daughter, brother or sister are no longer with us because of an opioid overdose. Is there anything more precious or urgent than the value of a life?

The best news is that these premature deaths are preventable! Many new innovations have spawned to put real-time insights into the hands of prescribing providers that detail what is in the patient’s body (lab tests) and what should be in their body (prescription drug monitoring program). Timely insights and #clinicaldecisionsupport will help providers make better opioid prescribing decisions. That gives me optimism that as we continue through this tumultuous year, we can make a difference by delivering the appropriate interventions to improve opioid prescribing while better informing clinical practice. These innovations will identify and protect at-risk patients and can make a dramatic and positive difference in outcomes!

I have asked a number of questions in this article and I will reiterate two important questions we need an answer to…. how many premature deaths, or in the more unfortunate view, how much tax revenue has to be lost for our federal and state legislators to start enforcing more stringent policies and procedures when it comes to the distribution of opioids? Ben Franklin may have been right about death and taxes, but people pay taxes and taxes help pay for critical services that can be used to prevent the tens of thousands of unnecessary deaths we continue to see each year by the opioid crisis.

By Lauren VanDenBoom
Share

August 9, 2021

In the August 2021 issue of Practical Laboratory Medicine (PLM), clinical leaders from hc1 (Diane Janowiak, MT(ASCP) and Wesley B. Wong, MMM, MD) and Quest Diagnostics (Lee H. Hilborne, MD, MPH and Terra White, Ph.D.) share Strategies for Laboratory Professionals to Drive Laboratory Stewardship

Focusing on the evolution of effective test utilization and implementation of lab stewardship as a leadership strategy to assure effective test use, they write that “implementing a laboratory stewardship program now presents a valuable opportunity for laboratory professionals to exercise leadership within health systems and to drive change toward realizing aims in healthcare.”

When structured and supported well, a lab stewardship program will organize and guide optimal, patient-centric lab testing. Estimates project that health systems can reduce costs up to $5 billion per year by eliminating redundant tests. Even more savings, and patient satisfaction, can be realized through increasing the use of appropriate tests that diagnose diseases early when treatment can be more effective.

A proposed framework

The authors propose a framework for program implementation that includes five key elements: 1) a clear vision and organizational alignment; 2) appropriate skills for program execution and management; 3) resources to support the program; 4) incentives to motivate participation; and, 5) a plan of action that articulates program objectives and metrics.

Drs. Wong and Hilborne also presented these five elements in May 2021 during a webinar hosted by Dark Daily offering Strategies for Laboratory Professionals to Drive Lab Stewardship to Reduce Cost, Eliminate Waste, and Improve Patient Care. 

“This framework builds upon principles of change management, with emphasis on engagement with clinical and administrative stakeholders and the use of clinical data as the basis for change,” the authors wrote in PLM. “These strategies enable laboratory professionals to cultivate organizational support for improving laboratory use and take a leading role in providing high-quality patient care.” 

A practical example

As an example of their framework in practice, the authors offer a case study featuring an 800-bed, three-hospital system in a metropolitan midwestern region with 17 ambulatory practices and four ambulatory surgery centers. The laboratory manager, informed by a conference that presented strategies for lab stewardship, assembled a small group of laboratorians including the laboratory medical director, the head of the clinical chemistry and microbiology sections including lead technologists in each of those sections, and the associate director for ancillary services. Based on their review, they wanted to better understand laboratory testing trends. Their initial action plan included normalizing the data, selecting specific tests for improvement, sharing the plan to attain leadership’s endorsement and identifying other team members. 

The team chose to focus initially on thyroid testing and identified two target areas: 1) inappropriate coding for patients with known thyroid disease and 2) ordering multiple thyroid tests for the initial assessment of symptomatic patients. For an initial action, the clinical practices agreed to change their ordering menu to promote effective test utilization. Four months after starting the program, generalist panels (initial encounter for suspected thyroid disease) decreased approximately 70%. Use of the incorrect diagnosis code also decreased and finance reported that third-party payer denials declined by 30%. Following the success with thyroid testing, the team received recognition and committed to expanding their efforts to include the diagnosis and management of diabetes mellitus and chronic kidney disease.

“Opportunities to improve laboratory services exist in every organization,” write the authors. “Some of these opportunities may be unique to a specific organization, while many are common across multiple healthcare systems.”

A starting point

Organizations looking for additional guidance in starting their own lab stewardship programs may find the four developmental stages of lab stewardship that Quest Diagnostics’ Donna Cooper, MS, MBA, and hc1’s Zach Berg define in their PLUGs webinar on Enabling Effective Lab Stewardship Programs helpful. The webinar, they help viewers determine which phase of development their Lab Stewardship program is in and opportunities to advance their Lab Stewardship program, as well as describe the features of the technology needed to support a Lab Stewardship program and multiple intervention methods.

If you are looking for guided support, hc1 and Quest Diagnostics can help. Quest, in partnership with hc1, aims to improve patient care and reduce costs across health systems nationwide by enabling Lab Stewardship programs. By combining professional advisory services with innovative technology, Quest Lab Stewardship powered by hc1 delivers real-time lab utilization insights necessary to progress and support at-scale optimization of laboratory testing. 

Watch this informative video or contact us to learn more. 

By Heather Stith
Share

July 6, 2021

Chronic diseases, including stroke, diabetes, and cancer, are the leading cause of death and disability in the United States. Healthcare professionals at all levels, and the communities and patients they work with, are therefore invested in reducing the impact of these diseases.

Depending on the role a person takes in a healthcare system, whether they are a public health official, a healthcare organization leader, a healthcare provider, or a patient, they are going to have different concerns and questions about chronic disease and different strategies for addressing those concerns and questions. No matter the level at which people are facing the problem of chronic disease, laboratory testing provides data that is integral to choosing the best way forward. 

Public health: How do we prevent chronic disease?

The National Health and Nutrition Examination Survey (NHANES) is an ongoing program to collect health data from a representative sample of Americans. The survey includes participant interviews and physical exams based on age and gender, including blood and urine tests for cholesterol, glucose, nutrition status, and kidney function. The data from this survey is used to determine the prevalence of chronic diseases and disease risk factors and to set standards for health measures such as blood pressure.

Using data collected in the NHANES program and other datasets, public health organizations focus their chronic disease prevention efforts on the most prevalent diseases and the major risk factors in their populations. For example, the National Center for Chronic Disease Prevention and Health Promotion targets the seven (7) most prominent chronic diseases for Americans:

  • Heart disease
  • Cancer
  • Chronic lung disease
  • Stroke
  • Alzheimer’s disease
  • Diabetes
  • Chronic kidney disease

The center also encourages people to reduce their risk of developing chronic diseases through healthy behaviors:

  • Stop smoking
  • Eat a healthy diet
  • Exercise regularly
  • Limit alcohol use

Promoting regular health screenings is an important strategy, because such screenings make people aware of medical conditions they have that can lead to the development of chronic disease. Some of these conditions, such as obesity or high blood pressure, are easily identified using a scale or blood pressure monitor. Other conditions, such as high cholesterol, require lab testing, a healthcare provider’s interpretation, and possibly multiple patient interactions with one or several healthcare organizations.

Healthcare organizations: How do we optimize chronic disease care?

Patients with chronic diseases account for 90% of annual healthcare costs in the United States, so healthcare leaders are always evaluating ways to reduce costs associated with caring for this patient population while maintaining the quality of care.  As an important factor in managing chronic disease, lab testing is a critical element of this analysis. 

Appropriate lab test utilization helps healthcare organizations improve clinical outcomes by reducing the risk of missed or delayed chronic disease diagnosis. Inappropriate use can lead to diagnostic errors and unnecessary healthcare costs. Standardizing test ordering, however, is not an easy task. It requires ongoing organizational, clinical, and technological resources and clear communication and buy-in among all the participants in the healthcare process.

Information needs to be shared across disciplines and departments for such an effort to be successful. Technology that compares lab test data from different systems and locations against accepted medical standards, such as hc1 PrecisionDx Advisor, can surface issues that cause lab testing related to chronic disease to be overused or underused across an organization. It can also monitor and measure the success of interventions to change ordering behavior, such as provider education, improvements to EMR test ordering interfaces, or requirements for additional approval for specialized testing. Of course, before the technology can do its job, the organization must do the hard work of gaining consensus on a course of action and implementing the agreed-upon interventions. 

Providers: How do we best diagnose and treat patients with chronic diseases?

There are four main reasons clinical providers order lab tests related to chronic disease:

  • Prevention: Test results for chronic disease risk factors can lead healthcare providers to recommend specific preventative measures to patients that will help them avoid or delay developing chronic disease. Chronic diseases can develop over a long time, sometimes without noticeable symptoms, which is why periodic screenings are recommended for patients with risk factors such as having a close family member with the disease or being middle-aged or older. When diseases such as cancer are caught in the early stages, they usually have a much better prognosis and a reduced cost of care.
  • Diagnosis: For some chronic diseases, the results of a single blood test may be all that is needed for a diagnosis. A 6.5% or higher result on an Hemoglobin-A1C blood test means the patient has diabetes, for example. Other test results are not so cut-and-dried. They may just indicate that more tests, scans, or procedures are needed to establish a diagnosis.
  • Treatment:  Lab testing helps healthcare providers track side effects and evaluate whether a medication, lifestyle change, or other treatments are working as expected.
  • Monitoring: Lab testing can check for recurrence or progression of a chronic disease.

Complicating matters is the fact that many U.S. adults, 40% to be specific, have more than one chronic disease to manage. It’s no wonder that providers want to make sure that they have as much data as possible, so they don’t miss anything.

But too much testing can lead to overdiagnosis and overtreatment and can cause patient harm. Consider this startling quote from the American Cancer Society Guidelines for the Early Detection of Cancer regarding PSA and other testing for prostate cancer, “Research has not yet proven that the potential benefits of testing outweigh the harms of testing and treatment.” 

Patients: How do we live with chronic disease?

High-value healthcare relies on clear communication between providers and patients, but studies have shown that both parties need to make fewer assumptions and ask more questions when it comes to testing.

The University of Michigan National Poll on Healthy Aging surveyed a sample of adults aged 50 to 80 and found:

  • 25% thought their healthcare providers often recommended unnecessary tests, medications, or procedures. Half of the patients who were recommended a test they thought was unnecessary had the test anyway.
  • 9% thought they needed a test, medication, or procedure that their provider said was unnecessary. Most patients received and understood the provider’s explanation for why it was unnecessary, but some patients didn’t receive any explanation or didn’t understand the explanation they were given.

In the BMJ Open Quality article, “Optimising laboratory monitoring of chronic conditions in primary care: a quality improvement framework,” researchers in the UK describe findings from interviews with patients who had their blood drawn for routine tests. “Patients wanted testing to tell them if they were ‘normal’, and if not, what needed to happen to return them to ‘normal’.” Yet, in many cases, testing results didn’t make a patient’s health situation any clearer. “Results generated by the laboratory were often presented in ways that obscured meaning and were prone to being misunderstood. In addition, results tended to reflect what is normal for a population. They rarely told us what is abnormal for the individual.”

The researchers advocate for a data-driven, systematic approach to appropriate test ordering, but emphasize that the success of such efforts relies on involving healthcare providers in the implementation of such an approach and making patients’ needs the driver for change. As the researchers state, the goal of lab testing should be to help patients and their caregivers make informed healthcare decisions.

Patients with chronic disease want answers they can act on. Tests that are unlikely to lead to any change in outcome cause harm by draining time, money, and energy from people who already have the daily stress of dealing with chronic illness.

To learn more about how hc1 is securely and intelligently integrating, normalizing, enriching, and transforming health data into the signals that identify risk and drive care decisions catering to each patient’s unique needs, click here to download our latest white paper